Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Liver disease symbols : ALNY save search
Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
NVO | News | $125.45 -2.48% 1.8M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
ALNY | $144.52 -1.06% 140K
|
Health Technology
|
| O: -2.06%
H: 0.0%
C: 0.0%
disease liver disease phase 1 liver trial
Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-07-21 (Crawled : 13:00) - biospace.com/
NVO | News | $125.45 -2.48% 1.8M
|
Health Technology
|
| O: 0.9%
H: 0.72%
C: 0.58%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: 0.58%
H: 0.42%
C: 0.38%
ALNY | $144.52 -1.06% 140K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -2.13%
disease liver disease treatment phase 1 results liver trial phase 2 phase 3
Dicerna Initiates Patient Dosing in ESTRELLA Phase 2 Clinical Trial of Belcesiran for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2021-06-22 (Crawled : 12:15) - biospace.com/
NVO | News | $125.45 -2.48% 1.8M
|
Health Technology
|
| O: -0.39%
H: 0.27%
C: -0.21%
LLY | News | $731.81 -1.86% 1M
|
Health Technology
|
| O: -0.02%
H: 0.44%
C: -0.53%
ALNY | $144.52 -1.06% 140K
|
Health Technology
|
| O: 0.08%
H: 1.01%
C: 0.9%
disease liver disease treatment phase 2 liver trial
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.